Original research, analysis, and commentary on regulatory science, medical device regulation, and quality management.
Why the benefit-risk “ratio” is arithmetic applied to quantities that don’t add up, and what should replace it.
When exactly is a device placed on the market? The constitutive test, and why it decides everything downstream.
How regulatory conformity quietly collapses during mergers and acquisitions, and how to keep it intact.
WEEE, RoHS, REACH and packaging waste as design obligations, not afterthoughts, and the penalties for forgetting.
See how rigorous analysis, strategic regulatory planning, and practical implementation combine to deliver measurable results across medical device and IVD markets.
